Sunday, April 25, 2021 8:19:31 AM
Apr. 07, 2021 3:40 PM ETOncology Pharma Inc. (ONPH)By: Aakash Babu, SA News Editor
Oncology Pharma (OTCPK:ONPH +10.0%) has signed a license agreement with Regen BioPharma for intellectual property pertaining to mRNA to be used in developing a therapy for treating pancreatic cancer.
The license agreement expands the company's portfolio of intellectual property that it plans to develop for niche biotechnology markets.
Successful Trading is the art of minimizing long term risk and maximizing capital allocation.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM